Mkppl-Atul

About Mkppl-Atul

This author has not yet filled in any details.
So far Mkppl-Atul has created 38 blog entries.

Oral Insulin, sub lingual – A product under development at MKPPL

2023-06-20T16:14:25+05:30

Oral insulin, which refers to insulin that is taken by mouth rather than being injected, has been a subject of research and development for many years. We at MKPPL are working on a sub lingual formulation. Our product so far is stable and is based on human insulin and is long lasting. While there have been challenges in developing an effective oral insulin formulation, if successfully developed, oral insulin could offer several benefits.

Oral Insulin, sub lingual – A product under development at MKPPL2023-06-20T16:14:25+05:30

MK-VitFe for CKD Patients

2024-05-27T15:47:11+05:30

Anaemia is a common complication among patients with chronic kidney disease (CKD). CKD refers to the gradual loss of kidney function over time, and it can lead to various health issues, including anemia. Iron levels are frequently low in CKD patients, and providing supplemental iron can help improve red blood cell production. This is where MKPPL iron fortification through MK-VitFe gets into place. The product being Transdermal helps in bringing up the lowered haemoglobin levels to normal levels without the need for iron injections.

MK-VitFe for CKD Patients2024-05-27T15:47:11+05:30

Dr. Satya Vadlamani : Addressing anemia through Transdermal Oil – Interventions at 15th Annual Pharma Leaders 2022

2024-08-10T01:55:17+05:30

Dr. Satya Vadlamani, Chairperson and Managing Director, Murli Krishna Pharma Private Ltd addressing on Transdermal Oil - Interventions for Addressing Anemia Among Children and Adolescents – A Murli Krishna Pharma Case Study at the at the 15th Annual Pharma Leaders Power Brand Awards 2022.

Dr. Satya Vadlamani : Addressing anemia through Transdermal Oil – Interventions at 15th Annual Pharma Leaders 20222024-08-10T01:55:17+05:30

The Changemakers: Dr. Satya Ramani Vadlamani, CMD – Murli Krishna Pharma Pvt. Ltd

2024-08-10T01:57:14+05:30

From establishing and leading Murli Krishna Pharma to change the Pharma landscape of India, Dr. Vadlamani has touched and transformed lives with her sheer passion, grit and determination. From being a Regulatory Compliant prefinished formulation intermediates facility in 2004 to becoming a finished dosage firm based on the FTF formulation, the growth trajectory of MKPPL, under the leadership of Dr. Vadlamani has been quite an inspiring one. She outlines MKPPL’s journey hosting to innovations, product pipeline & plans and concludes with an inspiring advice for youngsters.

The Changemakers: Dr. Satya Ramani Vadlamani, CMD – Murli Krishna Pharma Pvt. Ltd2024-08-10T01:57:14+05:30

Dr Satya Vadlamani Addressing on Healthcare Reforms at India Leadership Conclave 2021

2024-08-10T02:05:38+05:30

Dr. Satya Vadlamani, Founder, Chairperson & Managing Director of Murli Krishna Pharma Pvt. Ltd. addressing on Healthcare Reforms at the 12th Annual India Leadership Conclave & Indian Affairs Power Brand Awards 2021.

Dr Satya Vadlamani Addressing on Healthcare Reforms at India Leadership Conclave 20212024-08-10T02:05:38+05:30

Dr.Satya Vadlamani voted as Indian Affairs Inspirational Women Business Reformer of the Year 2021

2024-08-10T02:06:35+05:30

Dr.Satya Vadlamani,Chairperson & Managing Director, Murlikrishna Pharma Pvt.Ltd. voted as Indian Affairs Inspirational Women Business Reformer of the Year 2021 at the iconic & prestigious 12th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2021.

Dr.Satya Vadlamani voted as Indian Affairs Inspirational Women Business Reformer of the Year 20212024-08-10T02:06:35+05:30

A step towards Anemia Mukt Bharat

2022-08-11T01:35:44+05:30

Dr Satya Vadlamani's contribution towards the building of the nation is immense, as apparent in the past more than two decades, which she has dedicated to bringing smiles to innumerable faces. Having established Murli Krishna Pharma Pvt. Ltd. with Dr Vijay Shastri and a group of 4 Directors, she commissioned the manufacturing plant in 2005, and within two years obtained the first European Union (EU) approval for a single molecule. Her experience of more than two decades helps her innovate and create out-of-the-box ideas and products in her current organization.

A step towards Anemia Mukt Bharat2022-08-11T01:35:44+05:30

BBC Interview July 2015

2024-08-10T00:52:08+05:30

India is the third largest producer of medicines in the world, an industry that employs nearly 50 million people. But only 15% of them are women. Satya Vadlamani is running her own manufacturing plant near the city of Pune, Murli Krishna Pharma. The BBC went to meet her.

BBC Interview July 20152024-08-10T00:52:08+05:30
Golden Rectangle thin 2

Murli Krishna Pharma

Upcoming Events

No Events Scheduled Currently…

Quick Links

All information and material on this site is provided on an “as is” basis, and without guarantees or warranties of any kind, express or implied. Furthermore, any ideas and/or information provided or gained from this site would not necessarily reflect the views of Murli Krishna Pharma Pvt. Ltd. or its directors or employees.
|
The materials and/or information available or obtained at/through this site is/are not guaranteed or warranted in terms of completeness, correctness, accuracy, reliability or otherwise howsoever by Murli Krishna Pharma Pvt. Ltd. or its directors or employees.
|
The information presented on this web site does not constitute an offer for sale in territories where it is not permitted by Patent Law.

© 2016 - 2026 - Murli Krishna Pharma • All Rights Reserved | Website designed & maintained by Mediavault

Factory Address

Business Card

Connect Via WhatsApp

WhatsApp Us

Search


This website uses cookies and third party services. Please refer to our Privacy Policy for more information Settings
Accept All Decline

Necessary Cookies

These cookies are necessary for the proper functioning of this website and better user experience. By continuing to browse this website you agree to their usage. For details please refer to our Privacy Policy.

Tracking Cookies

These cookies allows the website to remember user preferences, track user behavior across the site. The primary purpose of tracking cookies is to enable personalized experiences and website analytics.

Third Party Embeds

The website uses Third Party Embeds to present rich media content. You can control the data collected by these third party services by selecting the choices below. If you choose not to opt in now, you may opt in when you decide to interact with the content on the website.
Go to Top